| 产品详情 |
| Edit |   |
| Product Name | Lipoprotein, Low Density, Oxidized, Human (LDL) |
| Description | Purified to homogeneity by ultra-centrifugation. Oxidized using 20uM cupric sulfate in PBS at 37°C for 24 hours. Oxidation is terminated with excess EDTA. The level of oxidation is measured using TBARS (Thiobarbituric acid reactive substances) determination using a Malondialdehyde (MDA) standard. Low density lipoprotein (LDL) oxidative modification is one of the major processes involved in atherosclerosis along with other degenerative disorders. Oxidised LDL is preferentially accumulated by macrophages which become so called foam cells within the atheromatous plaque and contributes to the accumulation of cholesterol, typical of atherosclerosis. Applications: Suitable for use in Functional Assays. |
| Size | 2mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | L2601-10M |
| Price | |
| Order / More Info | Lipoprotein, Low Density, Oxidized, Human (LDL) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|